Avalon GloboCare Corp operates commercial real estate in the US and China, and offers medical-related consulting services, immunotherapy, and second opinion/referral services. It is primarily focused on developing AVA-001 and AVA-011, with RNA-based FASH-CARTM cell therapy platform also in development. The company also has a strategic partnership to develop an S-layer vaccine against SARS-CoV-2 and coronavirus that causes COVID-19 disease.